Health Care Equipment

Accelerate Diagnostics

Accelerate Diagnostics Inc Expects 2.7% Revenue Growth and 49 Cent Loss Per Share in Q Report

Accelerate Diagnostics Inc. Files 10-K Year-End Report Amendment

Phillips Jack Sells Accelerate Diagnostics Stock to Cover Tax Obligations

Accelerate Diagnostics Inc reports quarterly financial performance with adjusted loss per share of 38 cents

Accelerate Diagnostics released FY2024 annual earnings on March 21 (EST), actual revenue 11.7 M USD (forecast 11.9 M USD), actual EPS -2.1476 USD (forecast -2.3 USD)

Accelerate Diagnostics released FY2024 Q4 earnings on March 21 (EST), actual revenue 2.816 M USD (forecast 3 M USD), actual EPS -0.3804 USD (forecast -0.5 USD)

Accelerate Diagnostics, Inc. Submits 510(k) Application for Accelerate WAVE™ System to FDA

Accelerate Diagnostics released FY2024 Q3 earnings on November 7 After-Market (EST), actual revenue $2.975M (forecast $3M), actual EPS -$0.5875 (forecast -$0.47)

Accelerate Diagnostics released FY2024 9 Months Earnings on November 7 After-Market (EST), with actual revenue of 8.882M USD and EPS of -1.8306

Accelerate Diagnostics to Release FY2024 Q3 Earnings on November 7 After-Market EST, Forecast Revenue 3 M USD, EPS -0.47 USD

Analysts initiate coverage on Accelerate Diagnostics

NASDAQ notifies the company of compliance with the minimum bid price requirement

Accelerate Diagnostics released FY2023 Cumulative 3Q Earnings on November 9, 2023 (EST), with Revenue of 9.032M USD and EPS of -4.6204

Republic Power

Brand Engagement Network

Society Pass

Intelligent Living Application

3 E Network Tech

Globavend

CCSC Tech

Sidus Space

Tryhard

Dreamland

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap